Efficacy News and Research

RSS
FDA grants approval for Dyax' KALBITOR for treating HAE patients

FDA grants approval for Dyax' KALBITOR for treating HAE patients

Missouri scientists discover aspirin and Tylenol can inhibit vaccine efficacy

Missouri scientists discover aspirin and Tylenol can inhibit vaccine efficacy

CHS introduces the Optic onsite health care solution

CHS introduces the Optic onsite health care solution

Teva Pharmaceutical Industries submits a BLA for its G-CSF XM02

Teva Pharmaceutical Industries submits a BLA for its G-CSF XM02

Positive data from Provectus Pharmaceuticals' psoriasis and atopic dermatitis trials

Positive data from Provectus Pharmaceuticals' psoriasis and atopic dermatitis trials

50 U.S. Hospitals approve Osteotech's Plexur M bone-polymer biocomposite

50 U.S. Hospitals approve Osteotech's Plexur M bone-polymer biocomposite

Amgen to present updated data on Nplate at the 2009 ASH meeting

Amgen to present updated data on Nplate at the 2009 ASH meeting

European Commission and the EMEA approve Angiox in primary PCI for STEMI

European Commission and the EMEA approve Angiox in primary PCI for STEMI

Article on TYSABRI for treating patients with multiple sclerosis published

Article on TYSABRI for treating patients with multiple sclerosis published

Completion of Phase I study of CPSI-2364 announced by Cytokine PharmaSciences

Completion of Phase I study of CPSI-2364 announced by Cytokine PharmaSciences

University of Navarra Hospital launches clinical trials to assess the efficacy of immunotherapy treatment

University of Navarra Hospital launches clinical trials to assess the efficacy of immunotherapy treatment

USPTO issues Notice of Allowance for Titan Pharmaceuticals' Probuphine patent application

USPTO issues Notice of Allowance for Titan Pharmaceuticals' Probuphine patent application

Research shows many factors can impact people's decisions on getting vaccinated

Research shows many factors can impact people's decisions on getting vaccinated

Clinical trials of personalised vaccines to fight glioblastomas

Clinical trials of personalised vaccines to fight glioblastomas

QRxPharma commences Phase 3 pivotal trial of MoxDuo IR

QRxPharma commences Phase 3 pivotal trial of MoxDuo IR

Bayer Healthcare Pharmaceuticals commences enrollment in florbetaben Phase III clinical trials

Bayer Healthcare Pharmaceuticals commences enrollment in florbetaben Phase III clinical trials

MagForce Nanotechnologies initiates conformity assessment procedure for its Nano-Cancer therapy

MagForce Nanotechnologies initiates conformity assessment procedure for its Nano-Cancer therapy

Eli Lilly's Cymbalta receives FDA approval

Eli Lilly's Cymbalta receives FDA approval

Micromet to present new results from its blinatumomab study at the ASH meeting

Micromet to present new results from its blinatumomab study at the ASH meeting

Spectrum Pharmaceuticals completes enrollment in apaziquone Phase 3 trial

Spectrum Pharmaceuticals completes enrollment in apaziquone Phase 3 trial

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.